Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 1
2019 2
2022 1
2023 3
2024 1
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field.
Liu KX, Shaaban SG, Chen JJ, Bagatell R, Lerman BJ, Catalano PJ, DuBois SG, Shusterman S, Ioakeim-Ioannidou M, Yock TI, Shamberger RC, Mattei P, Vu L, Elhalawani H, Dusenbery KE, Vo KT, Huang MS, Friedmann AM, Diller LR, Marcus KJ, MacDonald SM, Terezakis SA, Braunstein SE, Hill-Kayser CE, Haas-Kogan DA. Liu KX, et al. Among authors: shaaban sg. Radiother Oncol. 2024 Sep;198:110384. doi: 10.1016/j.radonc.2024.110384. Epub 2024 Jun 15. Radiother Oncol. 2024. PMID: 38880415 Free PMC article.
Executive Summary of the American Radium Society Appropriate Use Criteria for Extranodal NK/T-Cell Lymphoma.
Dandapani SV, Ahmed S, Robinson T, Advani R, Bates J, Constine LS, Dabaja B, Ha CS, Hoppe BS, Vega RM, Peterson JL, Pinnix CC, Plastaras J, Shaaban SG, Wu SY, Milgrom SA. Dandapani SV, et al. Among authors: shaaban sg. Int J Radiat Oncol Biol Phys. 2026 Mar 3:S0360-3016(26)00429-3. doi: 10.1016/j.ijrobp.2026.02.236. Online ahead of print. Int J Radiat Oncol Biol Phys. 2026. PMID: 41785936 Review.
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses.
Welsh JW, Tang C, de Groot P, Naing A, Hess KR, Heymach JV, Papadimitrakopoulou VA, Cushman TR, Subbiah V, Chang JY, Simon GR, Ramapriyan R, Barsoumian HB, Menon H, Cortez MA, Massarelli E, Nguyen Q, Sharma P, Allison JP, Diab A, Verma V, Raju U, Shaaban SG, Dadu R, Cabanillas ME, Wang K, Anderson C, Gomez DR, Hahn S, Komaki R, Hong DS. Welsh JW, et al. Among authors: shaaban sg. Cancer Immunol Res. 2019 Dec;7(12):1903-1909. doi: 10.1158/2326-6066.CIR-18-0793. Epub 2019 Oct 28. Cancer Immunol Res. 2019. PMID: 31658994 Free PMC article. Clinical Trial.
15 results